The value of endoscopic healing index monitoring for guiding infliximab dosing in patients with Crohn's disease

被引：0
|
作者：
Kantasiripitak, W.
Mathot, R.
Oldenburg, B.
Buisson, A.
Ferrante, M.
Laharie, D.
D'Haens, C.
Vermeire, S.
Dreesen, E.
机构：
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab076.620
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P497
引用
收藏
页码：S481 / S482
页数：3
相关论文
共 50 条
  • [21] MUCOSAL HEALING IN PATIENTS TREATED WITH INFLIXIMAB IN CROHN'S DISEASE AND ULCERATIVE COLITIS
    Boyd, J.
    Lee, L.
    Lanzon-Miller, S.
    GUT, 2013, 62
  • [22] Flexibility in interval and dosing of infliximab enables maintained response of patients with Crohn's disease
    Schnitzler, Fabian
    Fidder, Herma
    Ferrante, Marc
    Noman, Maja
    Van Assche, Gert A.
    Hoffman, Ilse
    Vermeire, Severine
    Rutgeerts, Paul J.
    GASTROENTEROLOGY, 2008, 134 (04) : A658 - A658
  • [23] Targeting endoscopic outcomes through combined pharmacokinetic and pharmacodynamic monitoring of infliximab therapy in patients with Crohn's disease
    Dreesen, E.
    Baert, F.
    Laharie, D.
    Bossuyt, P.
    Bouhnik, Y.
    Buisson, A.
    Lambrecht, G.
    Louis, E.
    Oldenburg, B.
    Pariente, B.
    Pierik, M.
    van der Woude, C. J.
    D'Haens, G.
    Vermeire, S.
    Gils, A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S16 - S18
  • [24] THE COMBINATION OF PATIENT REPORTED OUTCOMES AND THE ENDOSCOPIC HEALING INDEX IS A GOOD SURROGATE MARKER OF ENDOSCOPIC DISEASE ACTIVITY IN PATIENTS WITH CROHN'S DISEASE
    Yarur, Andres J.
    Wolf, Douglas C.
    Savarino, Edoardo
    Giannini, Edoardo G.
    Berens, Brandon
    Bodini, Giorgia
    Lorenzon, Greta
    Bruss, Alexandra
    Jain, Anjali
    Dervieux, Thierry
    GASTROENTEROLOGY, 2022, 162 (07) : S626 - S626
  • [25] Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease
    Rutgeerts, Paul
    Gasink, Christopher
    Chan, Daphne
    Lang, Yinghua
    Pollack, Paul
    Colombel, Jean-Frederic
    Wolf, Douglas C.
    Jacobstein, Douglas
    Johanns, Jewel
    Szapary, Philippe
    Adedokun, Omoniyi J.
    Feagan, Brian G.
    Sandborn, William J.
    GASTROENTEROLOGY, 2018, 155 (04) : 1045 - 1058
  • [26] Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring
    Hemperly, Amy
    Dubinsky, Marla C.
    Yarur, Andres
    Afzali, Anita
    Hanauer, Stephen
    Kugathasan, Subra
    Long, Millie D.
    Rabizadeh, Shervin
    Sockolow, Robbyn
    Okada, Lauren
    Jain, Anjali
    Abreu, Maria T.
    Vande Casteele, Niels
    CROHNS & COLITIS 360, 2021, 3 (03) : 1 - 8
  • [27] Simultaneous Monitoring of the Inverse Relationship Between Endoscopic Healing Index Scores and Therapeutic Drug Monitoring Across Biologics in Crohn's Disease
    Seminerio, Jennifer
    Cortes, Thaeri
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S446 - S446
  • [28] Infliximab Dosing for Crohn's Disease: Too Much of a Good Thing?
    Kaddis, Atheer A.
    AMERICAN HEALTH AND DRUG BENEFITS, 2014, 7 (02): : 93 - 93
  • [29] Dosing infliximab in Crohn's disease: Is adjustment for body size justified?
    Grisic, A. -M.
    Huisinga, W.
    Reinisch, W.
    Kloft, C.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S325 - S326
  • [30] The Relationship Between the Endoscopic Healing Index and Magnetic Resonance Enterography in Crohn's Disease
    Smith, Emily S.
    Mahtani, Prerna
    Ahmed, Waseem
    Chen, Johnson
    Lukin, Dana J.
    Longman, Randy
    Burakoff, Robert
    Scherl, Ellen
    Battat, Robert
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S427 - S428
12345